ACE2 and prostate cancer: Ang (1–7), a heptapeptide converted from Ang I by ACE and from Ang II by ACE2, binds to Mas (MAS, coded by MAS1) and inhibits proliferation of prostate cancer lines (Krishnan et al., 2013).